• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Gastritis Treatment Market

    ID: MRFR/Pharma/4769-HCR
    90 Pages
    Rahul Gotadki
    October 2025

    Gastritis Treatment Market Research Report Information By Diagnosis (Blood Test and Endoscopy), Treatment (Acid Blocking Medicines and Antibiotics), Drug Distribution Channel (Retail Pharmacy), and End-User (Hospitals and Clinics) - Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Gastritis Treatment Market Infographic

    Gastritis Treatment Market Summary

    The Global Gastritis Treatment Market is projected to grow significantly from 0.14 USD Billion in 2024 to 0.56 USD Billion by 2035.

    Key Market Trends & Highlights

    Gastritis Treatment Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 13.45% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 0.56 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 0.14 USD Billion, reflecting the current demand for gastritis treatments.
    • Growing adoption of advanced treatment options due to increasing prevalence of gastritis is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.14 (USD Billion)
    2035 Market Size 0.56 (USD Billion)
    CAGR (2025-2035) 13.45%

    Major Players

    Abbott Laboratories, AstraZeneca PLC, Novartis AG, Microbiotix, Inc, Reddy’s Laboratories, Lupin Ltd, Perrigo Pharmaceutical, Cipla Inc., Pfizer Inc., SUN Pharmaceuticals Industries limited

    Gastritis Treatment Market Drivers

    Rising Prevalence of Gastritis

    The increasing incidence of gastritis globally is a primary driver of the Global Gastritis Treatment Market Industry. Factors such as unhealthy dietary habits, stress, and the prevalence of Helicobacter pylori infections contribute to this rise. In 2024, the market is valued at 0.14 USD Billion, reflecting a growing awareness and diagnosis of gastritis. As more individuals seek treatment, the demand for effective therapies is expected to surge, potentially leading to a market valuation of 0.56 USD Billion by 2035. This trend indicates a compound annual growth rate of 13.45% from 2025 to 2035, highlighting the urgency for innovative treatment options.

    Key Companies in the Gastritis Treatment Market market include

    Future Outlook

    Gastritis Treatment Market Future Outlook

    The Gastritis Treatment Market is projected to grow at a 13.45% CAGR from 2024 to 2035, driven by increasing prevalence, advancements in treatment options, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop novel drug formulations targeting specific gastritis types.
    • Leverage telemedicine for remote patient monitoring and consultations.
    • Invest in educational campaigns to raise awareness about gastritis prevention.

    By 2035, the Gastritis Treatment Market is expected to achieve substantial growth, reflecting enhanced treatment accessibility and innovation.

    Market Segmentation

    Market Players

    • SUN Pharmaceuticals Industries limited
    • Pfizer Inc.
    • Cipla Inc.
    • Perrigo Pharmaceutical
    • Lupin Ltd
    • Reddy’s Laboratories
    • Microbiotix, Inc
    • Novartis AG
    • AstraZeneca PLC
    • Abbott Laboratories

    Intended Audience

    • Potential Investors
    • Market Research and Consulting Service Providers
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Pharmaceutical Manufacturers and Suppliers

    Gastritis Treatment Market Overview

    • SUN Pharmaceuticals Industries limited
    • Pfizer Inc.
    • Cipla Inc.
    • Perrigo Pharmaceutical
    • Lupin Ltd
    • Reddy’s Laboratories
    • Microbiotix, Inc
    • Novartis AG
    • AstraZeneca PLC
    • Abbott Laboratories

    Gastritis treatment Market, By Region

    • Canada
    • US
    • Eastern Europe
    • Rest of Western Europe
    • Spain
    • Italy
    • UK
    • France
    • Germany
    • Western Europe
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Rest of the Middle East & Africa       
    • Qatar
    • Kuwait
    • Oman
    • Saudi Arabia
    • United Arab Emirates
    • Potential Investors
    • Market Research and Consulting Service Providers
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Pharmaceutical Manufacturers and Suppliers

    Gastritis Treatment Market Segmentation

    • Others
    • X-ray of upper digestive system
    • Endoscopy
    • Blood test
    • Histamine Blockers
    • Antacids
    • Antibiotics
    • Acid-blocking medicines
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
    • Others
    • Hospital & Clinics
    • Canada
    • US
    • Eastern Europe
    • Rest of Western Europe
    • Spain
    • Italy
    • UK
    • France
    • Germany
    • Western Europe
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Rest of the Middle East & Africa       
    • Qatar
    • Kuwait
    • Oman
    • Saudi Arabia
    • United Arab Emirates
    • Potential Investors
    • Market Research and Consulting Service Providers
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Pharmaceutical Manufacturers and Suppliers

    Gastritis Treatment Market, by End-User

    • Others
    • Hospital & Clinics
    • Canada
    • US
    • Eastern Europe
    • Rest of Western Europe
    • Spain
    • Italy
    • UK
    • France
    • Germany
    • Western Europe
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Rest of the Middle East & Africa       
    • Qatar
    • Kuwait
    • Oman
    • Saudi Arabia
    • United Arab Emirates
    • Potential Investors
    • Market Research and Consulting Service Providers
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Pharmaceutical Manufacturers and Suppliers

    Gastritis Treatment Market, by Diagnosis

    • Others
    • X-ray of upper digestive system
    • Endoscopy
    • Blood test
    • Histamine Blockers
    • Antacids
    • Antibiotics
    • Acid-blocking medicines
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
    • Others
    • Hospital & Clinics
    • Canada
    • US
    • Eastern Europe
    • Rest of Western Europe
    • Spain
    • Italy
    • UK
    • France
    • Germany
    • Western Europe
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Rest of the Middle East & Africa       
    • Qatar
    • Kuwait
    • Oman
    • Saudi Arabia
    • United Arab Emirates
    • Potential Investors
    • Market Research and Consulting Service Providers
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Pharmaceutical Manufacturers and Suppliers

    Gastritis Treatment Market, by Treatment type

    • Histamine Blockers
    • Antacids
    • Antibiotics
    • Acid-blocking medicines
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
    • Others
    • Hospital & Clinics
    • Canada
    • US
    • Eastern Europe
    • Rest of Western Europe
    • Spain
    • Italy
    • UK
    • France
    • Germany
    • Western Europe
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Rest of the Middle East & Africa       
    • Qatar
    • Kuwait
    • Oman
    • Saudi Arabia
    • United Arab Emirates
    • Potential Investors
    • Market Research and Consulting Service Providers
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Pharmaceutical Manufacturers and Suppliers

    Gastritis Treatment Market, by Drug Distribution Channel

    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
    • Others
    • Hospital & Clinics
    • Canada
    • US
    • Eastern Europe
    • Rest of Western Europe
    • Spain
    • Italy
    • UK
    • France
    • Germany
    • Western Europe
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Rest of the Middle East & Africa       
    • Qatar
    • Kuwait
    • Oman
    • Saudi Arabia
    • United Arab Emirates
    • Potential Investors
    • Market Research and Consulting Service Providers
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Pharmaceutical Manufacturers and Suppliers

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 0.08 (USD Billion)
    Market Size 2024 0.14 (USD Billion)
    Market Size 2032 0.49 (USD Billion)
    Compound Annual Growth Rate (CAGR) 4.63 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Abbott Laboratories, AstraZeneca PLC, Novartis AG, Microbiotix, Inc, Reddy’s Laboratories, Lupin Ltd, Perrigo Pharmaceutical, Cipla Inc., Pfizer Inc., SUN Pharmaceuticals Industries limited
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers ·  Increasing occurrence of acute and chronic gastritis·  Advances in the area of medical technologies·  Increasing fast food chains worldwide·  Massive adoption of a sedentary lifestyle·  Advancement in endoscopy devices that increased the accuracy of diagnosis

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    Which region is expected to lead the Gastritis Treatment Market?

    The Americas is expected to lead the Gastritis Treatment Market.

    What are the key factors driving the Gastritis Treatment Market?

    Rising prevalence of chronic gastritis and advancement in endoscopy devices are adding market growth.

    What are the different end users of gastritis treatment?

    Hospitals and clinics are the end users of gastritis treatment.

    Who are the top players of Gastritis Treatment Market?

    Top players in the Gastritis Treatment Market include SUN Pharmaceuticals Industries Limited, Pfizer Inc., Cipla Inc., Perrigo Pharmaceutical, Lupin Ltd, Dr. Reddy’s Laboratories, Microbiotix, Inc, Novartis AG, AstraZeneca PLC, and Abbott Laboratories.

    What are the different strategies used by market players to create a dominance in the Gastritis Treatment Market?

    Different strategies used by market players to create a dominance in the Gastritis Treatment Market include acquisitions, product launches, partnerships, and collaborations.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions